tenk.fyi

Tempest Therapeutics, Inc.

TPSTNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$26.3M

37.2% YoY

EPS

$-6.33

67.5% YoY

Cash

$7.7M

74.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro